Opportunity Information: Apply for PAR 20 170
New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional) is a National Institutes of Health (NIH) cooperative agreement funding opportunity (PAR-20-170) focused on strengthening the nation s cancer surveillance system by modernizing how cancer registry data are collected, integrated, and expanded. The core aim is to advance surveillance science by backing practical, innovative informatics tools and methods that help population-based cancer registries capture information more efficiently and with better detail, accuracy, and timeliness. The emphasis is not just on research in the abstract, but on building or improving real-world registry infrastructure so the resulting data are more useful for high-quality cancer research across the U.S.
The FOA specifically supports projects that develop, adapt, apply, scale up, and validate tools and methods that improve cancer registry operations and outputs. In plain terms, the work should make it easier for registries to gather core cancer data and to bring in additional data elements that are increasingly important for modern cancer research. That can include better approaches for data collection workflows, improved integration of data from multiple sources, and methods that increase the breadth of what registries can reliably capture. A key expectation is that the proposed tools or methods will be tested and validated in ways that demonstrate they can work in practice, at scale, within registry environments, rather than remaining as small pilot concepts.
A central requirement is partnership with U.S. population-based central cancer registries, and the partnership must involve at least two different registries. This means applicants need to build proposals around active collaboration with multiple registries to ensure the tools and methods are relevant, implementable, and generalizable across more than one setting. The partnership requirement also signals that NIH is looking for projects that can move the field forward broadly, not solutions tailored to a single registry s unique constraints. Because the award mechanism is a cooperative agreement (U01), recipients should expect substantial involvement from the funding agency during the project, with closer coordination and shared stewardship than is typical for a standard research grant.
The opportunity is categorized under the broad activity areas of education and health, and it is associated with CFDA numbers 93.394, 93.395, and 93.399. The closing date listed for the opportunity is 2023-06-06, and the FOA record shows a creation date of 2020-04-15. While the excerpt does not provide an award ceiling or the expected number of awards, the intent is clearly oriented toward enabling registry-focused informatics advancements that can materially improve the national cancer surveillance enterprise.
Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly highlights additional eligible applicant groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.
At the same time, there are clear limits related to foreign involvement. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible to apply. However, the FOA notes that foreign components, as defined in the NIH Grants Policy Statement, are allowed, which typically means certain project elements may involve foreign collaboration or resources under NIH rules even though the applicant organization itself must be eligible and U.S.-based.
Overall, this FOA is aimed at teams that can combine informatics, cancer surveillance expertise, and strong multi-registry partnerships to deliver tools and methods that materially upgrade the cancer registry ecosystem. The intended payoff is better registry infrastructure and richer, more integrated registry data that can support more timely and rigorous cancer surveillance and research across the United States.Apply for PAR 20 170
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394, 93.395, 93.399.
- This funding opportunity was created on 2020-04-15.
- Applicants must submit their applications by 2023-06-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: 2020 Office of Naval Research (ONR) Global Research Opportunity: Global-X Challenge
Previous opportunity: Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 20 170
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 20 170) also looked into and applied for these:
| Funding Opportunity |
|---|
| Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Apply for PA 20 172 Funding Number: PA 20 172 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) Apply for PAR 20 180 Funding Number: PAR 20 180 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) Apply for PAR 20 179 Funding Number: PAR 20 179 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Research Project Grant (Parent R01 Clinical Trial Required) Apply for PA 20 183 Funding Number: PA 20 183 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed) Apply for PAR 20 182 Funding Number: PAR 20 182 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) Apply for PA 20 190 Funding Number: PA 20 190 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) Apply for PA 20 208 Funding Number: PA 20 208 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed) Apply for RFA DA 21 019 Funding Number: RFA DA 21 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) Apply for PA 20 149 Funding Number: PA 20 149 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) Apply for PA 20 151 Funding Number: PA 20 151 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) Apply for PAR 20 221 Funding Number: PAR 20 221 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 20 225 Funding Number: PAR 20 225 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional) Apply for PAR 20 224 Funding Number: PAR 20 224 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 - Clinical Trial Optional) Apply for RFA DA 21 013 Funding Number: RFA DA 21 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) Apply for RFA CA 20 039 Funding Number: RFA CA 20 039 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) Apply for RFA CA 20 038 Funding Number: RFA CA 20 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional) Apply for RFA DA 21 009 Funding Number: RFA DA 21 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Regional Medical Libraries for the Network of the National Library of Medicine (UG4) Apply for RFA LM 20 001 Funding Number: RFA LM 20 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed) Apply for PAR 20 241 Funding Number: PAR 20 241 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed) Apply for RFA CA 20 042 Funding Number: RFA CA 20 042 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 170", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
